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Abstract 
Common complex diseases are likely influenced by the interplay of hundreds, or even 
thousands, of genetic variants. Converging evidence shows that genetic variants with 
low-marginal-effects (LME) play an important role in disease development. Despite their 
potential significance, discovering LME genetic variants and assessing their joint association 
on high-dimensional data (e.g., genome-wide association studies) remain a great challenge. 
To facilitate joint association analysis among a large ensemble of LME genetic variants, we 
proposed a computationally efficient and powerful approach, which we call Trees Assembling 
Mann-Whitney (TAMW). Through simulation studies and an empirical data application, we 
found that TAMW outperformed multifactor dimensionality reduction (MDR) and the 
likelihood-ratio-based Mann-Whitney approach (LRMW) when the underlying complex 
disease involves multiple LME loci and their interactions. For instance, in a simulation with 
20 interacting LME loci, TAMW attained a higher power (power=0.931) than both MDR 
(power=0.599) and LRMW (power=0.704). In an empirical study of 29 known Crohn’s 
disease (CD) loci, TAMW also identified a stronger joint association with CD than those 
detected by MDR and LRMW. Finally, we applied TAMW to Wellcome Trust CD GWAS to 
conduct a genome-wide analysis. The analysis of 459K single nucleotide polymorphisms was 
completed in 40 hours using parallel computing, and revealed a joint association predisposing 
to CD (p-value=2.763e-19). Further analysis of the newly discovered association suggested 
that 13 genes, such as ATG16L1 and LACC1, may play an important role in CD 
pathophysiological and etiological processes. 
Key words: high-dimensional data, joint association analysis, Crohn’s disease 
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Introduction 
With the rapid advances in high throughput technologies, genome-wide association studies 
(GWAS) have been widely undertaken to study the genetic causes of common complex 
diseases. The increasing number of associated loci discovered from these studies will likely 
shed light on the underlying disease pathophysiological and etiological processes, as well as 
promote genome-based translational research. Nevertheless, a substantial proportion of the 
genetic variants that contribute to common complex diseases remain uncovered[Eichler, et al. 
2010]. 
Studies suggest that genetic variants with low-marginal-effects (LME) could contribute to a 
significant proportion of disease heritability. For instance, a GWAS on human height found 
LME single nucleotide polymorphisms (SNPs) could account for nearly half of the total 
genetic variance[Yang, et al. 2010]. Despite their potential importance, LME SNPs are 
generally associated with moderate significance levels, and thus are rarely detected by a 
single locus approach using a stringent p-value threshold (e.g., 5e-8). Complex diseases are 
also likely influenced by numerous LME SNPs. For example, hundreds of genetic variants 
are estimated to be involved in Crohn’s Disease[Park, et al. 2010]. Identifying such a large 
number of genetic variants and considering their possible interactions poses a great challenge 
to genetic association research. 
Statistical approaches have been developed to search for joint associations among multiple 
genetic variants, with or without considering interactions. In this paper, we focused on joint 
association approaches allowing for possible interactions. Among these approaches, 
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Multifactor Dimensionality Reduction (MDR) has been widely used[Ritchie, et al. 2001]. 
MDR exhaustively searches all of the possible subsets of SNPs to find the best combination 
that divides individuals into a “high-risk” group and a “low-risk” group. In this way, MDR 
reduces dimensionality, making it suitable for a joint association analysis. However, the 
computation time required for an exhaustive search increases exponentially with the number 
of SNPs, making it infeasible to apply the method directly to genome-wide data.[Cordell 
2009] We had previously developed a likelihood-ratio-based Mann-Whitney (LRMW) 
approach for genome-wide joint association analysis allowing for interactions. The approach 
adopts a fast Mann-Whitney (MW) based forward selection algorithm[Ye, et al. 2011] to 
search the entire genome for disease susceptibility SNPs, and assesses their joint association 
using an LRMW test. However, the LRMW is conservative in selecting disease susceptibility 
SNPs, and tends to only detect joint associations among a limited number of 
strong-marginal-effect (SME) SNPs (e.g., less than 10 SNPs). This makes it less ideal for 
evaluating complex joint association involving hundreds or thousands of LME SNPs.  
To facilitate a joint association analysis on a large number of LME SNPs while allowing for 
possible interactions, we propose a Trees-Assembling Mann-Whitney approach (TAMW). 
TAMW uses a trees-assembling technique[Breiman 2001; De Lobel, et al. 2010; Jiang, et al. 
2009; Lunetta, et al. 2004; Schwarz, et al. 2010] to search the genome for 
disease-susceptibility SNPs, including LME SNPs, and then evaluates their joint association 
using an MW test. Through simulation studies and a real data application, we systematically 
evaluated the performance of TAMW, and compared it with MDR and LRMW. The new 
approach was then applied to Wellcome Trust Crohn’s Disease GWAS CD dataset of 459,091 
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SNPs for a genome-wide joint association analysis.  
Methods 
In TAMW, we build multiple tree models from bootstrap samples of original data and then 
combine these models into a trees-assembling model. We then evaluate the joint association, 
as well as individual contributions, of genetic variants selected into the assembling model 
(including a large number of LME genetic variants) using an MW test.  
Trees-Assembling Mann-Whitney Approach 
To illustrate the approach, we assume there are N individuals in the data. Each individual is 
genotyped with P SNPs. We first draw T bootstrap samples from the original data. For each 
bootstrap sample, we randomly select S SNPs from P SNPs, and then build a tree model by 
applying a forward selection algorithm[Ye, et al. 2011] to the selected SNPs. The forward 
selection algorithm starts with a null model without any SNPs, and then gradually selects 
SNPs to form multi-locus genotype groups. In step one, the algorithm searches S SNPs for a 
disease-susceptibility SNP to divide samples into two genotype groups (e.g., a group of 
individuals carrying AA genotype and the other group of individuals carrying Aa/aa 
genotypes), which gives the highest possible MW statistic. In step two, we search for the 
second SNP, considering its possible interaction with the first SNP, to split the two existing 
groups into four two-locus groups, associated with the highest possible Mann-Whitney 
statistic. A special case may occur when the same SNP is selected to further split the two 
genotype groups. In this particular case, the model contains only three genotype groups (i.e., 
AA, Aa, and aa) at step two. The whole splitting process continues until the number of 
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multi-locus genotypes reaches a pre-defined size. The idea of forward selection algorithm is 
inherited from the classic tree approach. However, it differs from tree in two aspects: 1) in 
each step, it only allows a single SNP to split existing genotype groups so that joint 
association model identified from forward selection algorithm is more consistent with 
existing models (e.g., multiple-interaction model[Marchini, et al. 2005]); 2) it adopts MW 
statistic as the model selection criteria, which facilitate the statistical significance assessment 
of selected joint association model, as demonstrated below. 
Assuming a total of Mt multi-locus genotypes in a tree model t (1 t T  ), we can calculate 
the likelihood ratio ( t
mLR ) for each multi-locus genotype (
t
mG ): 
( | )
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( | )
t
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l tt
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   , 
where D  and D  denote disease status and non-disease status, respectively. By repeatedly 
applying the forward selection algorithm to T bootstrap samples, we obtain an ensemble of 
tree models. Each tree model assigns an LR value ( t
iLR ,1 i n  ) to an individual i (1 i n  ) 
according to one’s multi-locus genotype (e.g., t t
i mLR LR , if i-th individual carries m-th 
multi-locus genotype). The assembling LR value ( TA
iLR ) for an individual i can thus be 
obtained by averaging the LR values over T tree models (
1
1 TTA t
i i
t
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T 
  ). 
Based on the ranks of the LR values, we can form the Trees-Assembling Mann-Whitney 
statistic to evaluate the joint association of the selected SNPs with the disease 
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where DN  and DN  represent the number of cases and non-cases. The kernel function 
is defined as 
1,      if 
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By assembling a large number of tree models, each comprised of different sets of SNPs, 
the new approach could simultaneously consider a large number of LME SNPs and their 
interactions. Randomly selecting a subset of SNPs that are not likely to be comprised of 
any SME SNPs allows TAMW to also increase the chances of considering important 
interactions among LME SNPs. 
Evaluating the joint association 
Given the above Mann-Whitney statistic, hypothesis testing can be formed to test the joint 
association: 
 0
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where 0U  equals 0.5 D DN N . ( )Var U  can be calculated as 
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Under the null hypothesis, Z follows a standard normal distribution asymptotically, which can 
be used to estimate the significance level of the detected joint association. However, model 
selection, ranking LR, and performing hypothesis testing on the same data could inflate Type 
I error. Although permutation test could be used to adjust the inflated significance level, it is 
not computationally feasible for a genome-wide joint association analysis, especially when 
the analysis involves complicated modeling (e.g., the assembling procedure). Alternatively, 
we can evaluate the joint association of the selected disease-susceptibility SNPs on an 
independent dataset (e.g., a replication dataset or a split sample). To test the joint associations 
on an independent dataset, we first apply the T tree models to the independent dataset, so that 
each subject is assigned T LR values. We then average the T LR values to form a TAMW 
statistic. Based on the TAMW statistic, we evaluate the significance of the joint association 
using equation (2). 
Individual contributions of genetic variants 
Importance measurements (IM) can be used to assess the individual contributions of genetic 
variants in the joint association. The IM is measured by comparing the joint association 
model with an interested SNP to the model without the SNP.  
Assuming that a specific SNP s has been selected in the Ts tree models, we can calculate the 
IM for each tree model t (1 st T  ) using a Z score, 
1 0
1 0 1 0( ) ( ) ( ) 2 ( , )
s s s
s t t t
t
s s s s s
t t t t t
U U U
Z
Var U Var U Var U Cov U U
 
 
  
,    (4) 
where 
1
s
tU  and 0
s
tU  are the MW values for the tree model t, with and without the SNP s, 
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respectively. 
1( )
s
tVar U  and 0( )
s
tVar U  are the corresponding variances, which can be 
calculated based on equation (3). 
1 0( , )
s s
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Given the IM( s
tZ ) for each tree model t, the individual contribution of the SNP s to the joint 
association can be measured by averaging IM values from all of the Ts tree models 
(
1
1 s
T
s
s t
ts
Z Z
T 
  ). 
Results 
Simulation Studies 
Through simulation studies, we evaluated the TAMW approach, and compared its 
performance with two existing approaches, MDR and LRMW. We first conducted a simple 
simulation to study the performance of three approaches under complex disease scenarios 
involving multiple LME loci, and their two-way and three-way interactions. To mimic a real 
disease scenario, we simulated the genotype data from the Wellcome Trust Crohn’s disease 
(CD) data, and introduced a combination of independent LME loci, two-way interactions and 
three-way interactions into the disease model. In the second simulation, we evaluated the 
performance of the three approaches under five different types of gene-gene interaction 
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models, varying from those with marginal effects to those with limited or no marginal effect. 
In both simulations, we started with simple disease models including only one gene-gene 
interaction, and then gradually increased the model’s complexity by including additional 
independent LME loci or interactions. 
For each simulation, we evaluated both type I error and power of the approaches. Power (type 
I error) is defined as the probability of identifying a significant joint association (i.e., p-value 
<0.05) when there is an (no) association. For TAMW and LRMW, we used 2/3 of the data to 
search for a joint association model, and then assessed the significance of the joint association 
model on the remaining 1/3 data using the MW based test. For MDR, we adopted the same 
procedure used in previous MDR papers[Moore, et al. 2007; Pattin, et al. 2009]by 
implementing a Tuned ReliefF filter to exclude noise SNPs, and then applying MDR on the 
remaining SNPs to search for a joint association. The significance of the joint association can 
be then obtained based on an extreme value distribution.[Pattin, et al. 2009] 
Simulation I 
The genotype data of simulation was generated based on 29 CD-associated SNPs from the 
Wellcome Trust CD study. To evaluate the type I error, we first simulated a null model 
comprised of no functional SNP (i.e., all 29 SNPs are noise SNPs). The power was then 
assessed under five disease models, comprised of 2, 5, 10, 15 and 20 SNPs, respectively. The 
first model represented a simple disease scenario with only one two-way interaction. As the 
number of functional SNPs increased, we gradually increased model complexity by 
introducing additional single-locus, two-way interaction and three-way interaction effects. At 
the same time, we decreased the effect-sizes of the functional SNPs so that each of them was 
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associated with a lower marginal effect. The details of the simulation settings were 
summarized in Table S1. The rationale behind the simulation was to evaluate the performance 
of the three approaches under a variety of disease models. While the first few models 
mimicked a simple disease caused by few SME SNPs, the later models were closer to a 
complex disease that involved a large number of LME SNPs and their interactions. 
We applied TAMW, MDR and LRMW on the simulated data, and calculated the type I error 
and power based on 1000 simulated replicates (Table I). The results showed that the type 1 
error from all three approaches was well controlled at the level of 0.05. For the simplest 
model with one two-way interaction, TAMW (Power=0.691) was comparable with MDR 
(Power=0.705) and LRMW (Power=0.812). As the number of functional SNPs increased and 
their effect-size decreased, TAMW demonstrated its advantage over the other two. When the 
number of disease-susceptibility SNPs was greater than 10, TAMW attained the highest 
power among the three approaches. For the most complicated model of 20 LME SNPs, the 
power of TAMW reached 0.931, much higher than MDR (Power=0.599) and LRMW 
(Power=0.704). 
Simulation II 
Statistical approaches may perform differently under various underlying gene-gene 
interaction models. For instance, MDR has a unique feature of capturing interactions with no 
marginal effect, while LRMW attains higher power when at least one of the interacted 
markers has a marginal effect. In this simulation, we considered five two-way interaction 
models. The first three interaction models were a multiplicative effect model (M1), a 
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multiplicative interaction model (M2) and a threshold interaction model (M3), 
respectively[Marchini, et al. 2005]. These models were commonly used in previous 
literatures and assumed marginal effects on both loci. The fourth interaction model (M4) 
came from a typical MDR simulation, assuming no marginal effect on either loci[Ritchie, et 
al. 2003]. The fifth interaction model (M5) represented another possible disease model with 
marginal effect on only one locus (Table S4). Similar to simulation I, we included 29 SNPs in 
the simulation data. First, a null model with no functional loci was simulated to assess the 
type I error. We then evaluated the power of the three approaches under each of five two-way 
interaction models. For each interaction model, we started with a simple disease model with 
one interaction between two LME loci, and gradually added LME loci to increase the model’s 
complexity, until a complex model was reached with five two-way interactions. For 
simplicity, we only included the same type of interaction into a model and assumed they were 
associated with same effect-size. 
We applied TAMW, MDR and LRMW to the simulated data. The type I error for TAMW, 
LRMW and MDR were 0.055, 0.042 and 0.042, respectively, which were well controlled at 
the level of 0.05. The three approaches had comparable power under the simple disease 
model with one interaction (Figure 1). While TAMW and LRMW were slightly more 
powerful than MDR under the interaction models with marginal effects (i.e., M1, M2, M3, 
and M5), MDR obtained more power than TAMW and LRMW when the interacted loci had 
no marginal effect (i.e., M4). However, as the number of interacting SNPs increased, the 
performance of TAMW improved significantly under interaction models with marginal 
effects, while the performance of LRMW and MDR only obtain limited improvement. 
13 
 
TAMW attained the highest power under the complex model with five interactions. For 
example, under the disease model with five threshold interactions (i.e., M3), the power of 
TAMW was much higher (Power=0.854) than the power of MDR (Power=0.276) and the 
power of LRMW (Power=0.378). Under the interaction model with no marginal effects (i.e., 
M4), all three approaches obtained a limited power increase as the number of LME SNPs 
increased. 
Application to Crohn’s Disease 
Crohn’s disease (CD) is a major form of inflammatory bowel disease[Hanauer 2006]. 
Genetics contribute significantly to CD, with an estimated sibling relative risk between 25 
and 42.[Russell and Satsangi 2004] However, known CD genetic variants only explain a 
small proportion of CD heritability. Franke et al[Franke, et al. 2010] recently conducted a 
meta-analysis and identified 71 CD-associated SNPs, explaining 23.2% of the total genetic 
variance. CD is likely caused by the interplay of hundreds or thousands genetic variants[Park, 
et al. 2010]. Although recent GWAS and meta-analysis have revealed numerous genetic loci 
strongly related to CD, a large proportion of LME loci remain to be discovered. The 
identification of these LME loci and their possible interactions should not only help elucidate 
how LME genetic variants interplay with each other within biological pathways to cause 
disease, but also explain additional heritability. 
For this purpose, we conducted a joint association analysis by using a large-scale Wellcome 
Trust GWAS data[Burton, et al. 2007], which is comprised of 1748 unrelated cases and 2938 
unrelated controls. A candidate gene analysis was carried out to evaluate joint associations 
among 29 known CD-associated SNPs[Barrett, et al. 2008]. Using the candidate gene data, 
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we also compared the performance of TAMW, MDR and LRMW. Moreover, in order to 
uncover unknown LME genetic variants and their interactions, we carried out a genome-wide 
joint association analysis by applying TAMW to a total of 459,091 SNPs. 
Joint Association Analysis among known loci 
We applied TAMW, MDR and LRMW to the Wellcome Trust CD dataset to evaluate joint 
associations among 29 known CD-associated SNPs. TAMW completed the analysis in 70 
seconds on a personal computer with two 2.50GHz CPUs and 3.25 GB of memory, which 
was comparable to LRMW (31 seconds) but much faster than MDR (1500 seconds). With the 
capacity to consider both SME SNPs and LME SNPs (Table S3), TAMW identified a joint 
association highly associated with CD (p-value=1.84e-39). On the other hand, MDR and 
LRMW only detected joint associations among 3 SME SNPs, which attained significance 
levels of 5.81e-05 and 6.25e-14, respectively (Table II). To gain an idea how TAMW would 
perform on SME SNPs alone, we applied TAMW to the 3 SNPs selected by MDR and 
LRMW. The joint association detected among these 3 SME SNPs by TAMW reached a 
comparable significance level (p-value=3.33e-16) with the one identified by LRMW. 
Importance measurement analysis followed the initial evaluation, to assess the individual 
contribution of the 29 SNPs to the joint association detected by TAMW. The analysis 
revealed the significant contributions of IL23R, ATG16L1, LACC1, TNFSF15 and NKX2-3 to 
the identified joint association. Among these five genes, IL23R and ATG16L1 were ranked as 
the most important genes (1
st
 and 2
nd
), which is consistent with the results of single locus 
analysis (Table S3), as well as the outcomes from joint association analyses using MDR and 
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LRMW (Table II). Aside from the evidence from our study, previous studies have repeatedly 
reported IL23R and ATG16L1 as being associated with CD[Cummings, et al. 2007; Duerr, et 
al. 2006; Okazaki, et al. 2008]. The remaining 3 top-ranked genes (i.e., LACC1, TNFSF15 
and NKX2-3) were not detected by MDR and LRMW. Yet, TAMW suggested that they could 
make a substantial contribution to the genetic susceptibility of CD, which is consistent with 
published literatures[Franke, et al. 2010; Umeno, et al. 2011; Yamazaki, et al. 2005; Yu, et al. 
2009]. Yamazaki et al[Yamazaki, et al. 2005] reported that TNFSF15 was associated with CD 
in both Japanese and European populations. Further, a cytology experiment indicated that the 
gene might function via the innate immune system to protect the intestinal barrier. Yu et al[Yu, 
et al. 2009] found that NKX2-3 gene expression is up-regulated in CD patients and suggested 
that the abnormal expression of the gene might alter gut migration of antigen-response and 
thus increase susceptibility to CD. The LACC1 gene was found to be associated with CD in 
multiple studies[Franke, et al. 2010; Umeno, et al. 2011], but its function in the etiology of 
CD remains unknown. 
Genome-wide Joint Association Analysis 
We conducted a genome-wide joint association analysis to search for novel gene variants, 
especially those LME variants, associated with CD. For the genome-wide joint association 
analysis, we simultaneously evaluated 459,091 SNPs that had passed the Wellcome Trust 
quality control criteria. We applied TAMW to two-thirds of the Wellcome Trust CD samples 
to search for a parsimonious joint association model associated with CD, and then applied the 
model to the remaining one-third of samples to assess its significance level. Due to the 
intensive computation, we performed the genome-wide joint association analysis on a 
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clustered machine. We paralleled the computations onto 20 CPUs (2.3GHz), with each CPU 
assigning 4 GB of memory. The joint association model was converged at about 2000 trees 
(Figure S1) and a total of 20,000 trees were grown to ensure that all of the SNPs were 
covered[Lunetta, et al. 2004; Schwarz, et al. 2010]. 
The genome-wide analysis was completed in 40 hours, which identified a joint association 
significantly associated with CD (p-value=2.763e-19). To gain better insight into the joint 
association, we assessed the individual contribution of each SNP through their IM values. We 
focused on the 100 highest IM-ranked SNPs (Table S4), from which we identified thirteen 
genes (Table III). Among the thirteen genes, seven of them (i.e., NOD2, IL23R, ATG16L1, 
PTPN2, CYLD, C5orf56, and SLC22A5) had previously been reported as associated with CD 
[Barrett, et al. 2008; Ferguson, et al. 2007; Franke, et al. 2010]. In our analysis, these seven 
genes were consistently top-ranked in both single locus analysis (via PLINK, [Purcell, et al. 
2007]) and the joint association analysis (via TAMW). For the remaining six genes, LACC1, 
ZGPAT, TNFSF15, IL12RB2, GALNT2, and MCF2L2, single locus analysis showed that they 
were only moderately associated with CD, while joint association analysis indicated they 
might interact to play an important role in CD disease etiology.  
In fact, previous studies have confirmed the association of three of these six LME genes 
(LACC1, ZGPAT and TNFSF15) with CD. Franke et al[Franke, et al. 2010] detected the 
association of LACC1 and ZGPAT with CD in a meta-analysis study based on 6333 cases and 
15056 controls. In another GWAS study of a Japanese population, Yamazaki et al[Yamazaki, 
et al. 2005] revealed that TNFSF15 was associated with CD. Although no previous study had 
reported the association of IL12RB2 and GALNT2 with CD, they have plausible biological 
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links to CD. IL12RB2 interacts with IL23R in the IL23 signaling pathway—a critical 
regulator in CD[Wang, et al. 2009]. GALNT2 might function in maintenance of the mucin 
layer by interacting with NOD2, which could influence susceptibility to CD[Phillips, et al. 
2009]. MCF2L2 has been reported as a susceptibility loci in Type 1 and Type 2 
diabetes[Takeuchi, et al. 2008; Zhang, et al. 2010]; our study suggests it may also relate to 
CD. 
Discussion 
Despite the recent success of genome-wide association studies (GWAS), a large proportion of 
the genetic variations associated with complex diseases remain unknown. Research has 
revealed the important role of LME genetic variants in disease pathophysiology and etiology. 
Nevertheless, the majority of the LME genetic variants are understudied because of their 
moderate association with diseases. Hundreds or perhaps even thousands of LME genetic 
variants lie on the genome. Although individual LME genetic variant has limited effect on 
diseases, they could act jointly to account for a significant part of the unexplained variance. 
We developed a new approach, TAMW, to evaluate the joint association of a large number of 
LME genetic variants and their potential interactions with a disease. Through simulation 
studies, we were able to show that TAMW had advantages over two existing approaches, 
LRMW and MDR, when the disease involved multiple LME genetic variants and their 
interactions. We also conducted an empirical study by applying TAMW to Wellcome Trust 
CD GWAS data with nearly 500K SNPs. The genome-wide analysis was completed in 40 
hours. The identified SNPs were then ranked based on their IM values, from which we found 
thirteen genes predisposing to CD. Previous genetic association studies have suggested that 
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these genes play important roles in the etiology of Crohn’s disease. Yet, among the thirteen 
genes, six of them were associated with low marginal effect, and would likely be missed in a 
single locus analysis. Compared with a single-locus analysis that only considers marginal 
effects, the joint association analysis takes both marginal effect and interaction effect into 
account, and thus provides a more comprehensive assessment of genetic variants’ role in 
disease association. 
Compared to existing approaches, TAMW has four unique features: 1) TAMW could 
simultaneously consider a large number of LME SNPs and their interactions through 
assembling multiple tree models. Although each tree model is moderately associated with 
disease outcomes, combining them together could result in great improvement in association. 
2) By randomly selecting a subset of genetic variants, likely comprised of only LME SNPs, 
TAMW also increases the chance of identifying important interactions among the LME SNPs. 
3) TAMW is well designed for computational efficiency with the capacity of handling GWAS 
data. It could easily parallel the computation and build the forward trees simultaneously on a 
cluster machine. 4) The results from TAMW can be interpreted in several ways. From TAMW, 
we can assess the significance of a joint association with a disease. Moreover, a strong joint 
association also indicates its potential for risk prediction. In fact, MW statistic can be easily 
transformed to AUC (
D D
U
AUC
N N
 ) to measure the prediction ability of multiple genetic 
markers. The one-to-one relationship between MW statistic and AUC also links the MW 
statistic to disease heritability. As shown by So et al[So and Sham 2010], heritability could be 
inferred from AUC by knowing the disease prevalence.  
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The search algorithm in TAMW is developed based on the concept of ensemble learning, 
which has been adopted in other ensemble learning approaches, such as Random Forest (RF). 
However, unlike the commonly used classification and prediction approach, RF, TAMW is an 
approach designed for genetic association analyses, and has several unique features. Firstly, 
TAMW is built under the framework of MW statistic, which facilitates the association test of 
multiple disease-susceptibility markers with the disease. Secondly, instead of CART, TAMW 
uses a forward selection algorithm to build model. As we demonstrated elsewhere[Lu, et al. 
2012], the forward selection algorithm is computationally more efficient, making TAMW 
feasible for genome-wide association analyses. TAMW forms a Mann-Whitney statistic on 
the rank of LR values rather than actual LR values. Similar as other non-parametric 
approaches, it could be slightly less powerful than the parametric approaches comparing the 
LR values (e.g., t-test), when the assumption of normality satisfies. However, for complex 
disease models involving interactions, such assumption may not hold. When the assumption 
of normality is violated, non-parametric approaches, such as TAMW, could be powerful than 
the parametric approaches[Blair and Higgins 1981; Blair, et al. 1980].  
Although TAMW has several advantages over existing approaches, it also has certain 
limitations. TAMW, likes many ensemble learning approaches, does not explicitly model the 
interaction by estimating interaction effect sizes, which makes the interaction less 
interpretable. Moreover, the tradeoff to using the computationally efficient forward selection 
algorithm in TAMW is that at least one of the selected loci must have a reasonably strong 
marginal effect. When interaction exists among loci in the complete absence of main effects, 
the approach could have lower power as compared to an exhaustive search approach, MDR 
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(Figure 1). The TAMW described in this paper does not consider covariate adjustment. The 
easiest way to handle covariates in the TAMW is to build two models, one with covariates 
and the other without covariates. By comparing these two models, we are able to test the joint 
association, adjusting for covariate effects. Alternatively, we could build propensity 
scores[Jiang and Zhang 2011] or stratification scores[Allen and Satten 2011] on the 
covariates, and then use the scores as weights in the TAMW approach for covariate 
adjustment. 
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Figure 
Figure 1: Power comparison of LRMW, TAMW and MDR under five interaction 
models 
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Tables 
Table I: Power comparisons for TAMW, MDR and LRMW 
Table I: Power comparisons for TAMW, MDR and LRMW 
Method 
Power 
0 SNPs 2 SNPs 5 SNPs 10 SNPs 15 SNPs 20 SNPs 
TAMW 0.053 0.691 0.761 0.744 0.83 0.931 
MDR 0.024 0.705 0.570 0.434 0.462 0.599 
LRMW 0.054 0.812 0.771 0.699 0.686 0.704 
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Table II: Summary of the candidate gene analysis 
Chr. Gene SNPs TAMW MDR LRMW 
1p31 IL23R rs11465804 1
a
 +
b
 3
c
 
2q37 ATG16L1 rs3828309 2 + 2 
5q33  rs11747270 3   
18p11  rs2542151 4   
13q14 LACC1 rs3764147 5   
5p12  rs4613763 6 + 1 
9q32 TNFSF15 rs4263839 7   
1q25  rs9286879 8   
9q24  rs10758669 9   
10q24 NKX2-3 rs11190140 10   
  others 11~29   
p-value   1.84e-39 5.81e-05 6.25e-14 
 
a Rank of IM value from TAMW. 
b SNPs selected by MDR. 
c Number represents the selection sequence from LRMW. 
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Table III: Summary of GWAS analysis using TAMW 
Chr. Gene SNPs IM Rank 
Single-locus 
P-value 
Single-locus 
rank 
1p31 
IL23R 
rs2201841 3.38 12 6.51e-12 14 
rs11805303 2.90 26 8.11e-13 7 
rs10489629 2.45 54 6.05e-12 13 
rs6664119 2.19 84 7.54e-06 105 
IL12RB2 rs3790567 2.75 35 1.84e-05 133 
1q41 GALNT2 rs12751815 2.31 69 4.59e-04 651 
2q37 ATG16L1 
rs3792106 4.20 1 1.69e-11 19 
rs10210302 4.07 2 9.10e-14 2 
rs6752107 4.03 3 1.56e-13 4 
rs6431654 3.88 4 1.11e-13 3 
rs3828309 3.80 5 4.44e-13 6 
3q27 MCF2L2 rs2314349 2.61 44 4.35e-04 624 
5q31 
C5orf56 rs4540166 2.94 25 9.40e-06 110 
SLC22A5 
rs274547 2.16 88 7.65e-07 73 
rs274552 2.73 36 9.49e-07 79 
9q32 TNFSF15 rs6478108 2.42 59 9.20e-05 261 
13q14 LACC1 rs3764147 2.23 77 4.10e-05 183 
16q12 
NOD2 
rs17221417 2.91 27 1.14e-11 17 
rs3135499 2.82 30 1.21e-08 28 
rs2076756 2.46 52 8.35e-15 1 
rs2066843 2.27 73 1.48e-12 8 
rs1861759 2.47 51 8.01e-07 74 
rs748855 2.69 40 2.78e-07 63 
CYLD 
rs7342715 2.77 32 6.59e-09 26 
rs11076540 2.76 34 2.87e-08 39 
rs3135503 2.40 61 4.56e-08 45 
18p11 PTPN2 
rs16939895 3.07 17 5.88e-07 71 
rs7234029 2.90 28 4.06e-07 68 
rs3135503 2.40 61 4.56e-08 45 
20q13 ZGPAT 
rs6011040 2.50 47 9.12e-05 260 
rs2738758 2.10 94 1.95e-05 137 
30 
 
 
 
